| 1989 |
STI1 (yeast ortholog of STIP1) was identified as a stress-inducible gene encoding a ~66 kDa protein; disruption caused impaired growth at high and low temperatures, and overexpression trans-activated the SSA4 (HSP70) promoter, indicating a role in mediating the heat shock response. |
Gene disruption, overexpression with reporter gene fusion, two-dimensional gel electrophoresis |
Molecular and cellular biology |
Medium |
2674681
|
| 1997 |
Yeast Sti1 acts as a general co-chaperone at an intermediate step in the Hsp90-dependent maturation of client proteins (glucocorticoid receptor, v-Src); deletion of STI1 reduces GR and v-Src activity in vivo and increases GR-Ydj1 complexes, placing Sti1 downstream of Hsp70 (Ydj1) and upstream of mature Hsp90-client complexes. |
Genetic epistasis (sti1Δ combined with hsp90ts mutations, GR/v-Src activity assays), co-immunoprecipitation of client complexes in yeast |
Molecular and cellular biology |
High |
8972212
|
| 2000 |
Human STIP1 (StIP1) preferentially associates with unphosphorylated (inactive) Stat3 and also binds members of the Janus kinase (JAK) family; overexpression of the Stat3-binding domain of STIP1 blocks Stat3 activation, nuclear translocation, and Stat3-dependent transcription, suggesting STIP1 acts as a scaffold promoting JAK–Stat3 interaction. |
Co-immunoprecipitation, overexpression dominant-negative domain, reporter gene assay, nuclear translocation assay |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
10954736
|
| 2003 |
Sti1 is a non-competitive inhibitor of the Hsp90 ATPase; it binds both the N- and C-terminal domains of Hsp90 and prevents the N-terminal dimerization reaction required for efficient ATP hydrolysis, with the first 24 amino acids of Hsp90 being important for this interaction. |
In vitro ATPase assay, binding analysis with truncated Hsp90 constructs, kinetic inhibition analysis |
The Journal of biological chemistry |
High |
12525481
|
| 2005 |
Sti1p regulates Hsp70 and Hsp90 independently via distinct TPR domains: TPR1 mutations impair Hsp70 regulation (without affecting Hsp90), while TPR2A/TPR2B mutations impair Hsp90 regulation (without affecting Hsp70); Hsp90 is implicated as a TPR2B ligand; client folding requires Sti1p to bridge both chaperones simultaneously. |
Site-directed mutagenesis of TPR domains, yeast [PSI+] prion assay for Hsp70 activity, Hsp90-inhibitor assay for Hsp90 activity, client folding assays |
The Journal of biological chemistry |
High |
16100115
|
| 2005 |
STIP1/STI1 interacts with cellular prion protein (PrPC) via immunoprecipitation; the OR and N-terminal hydrophobic region of PrPC are required for PrPC-STI1-mediated activation of superoxide dismutase (SOD) activity and cell survival signaling. |
Co-immunoprecipitation, inhibitory peptide competition assays, SOD activity assay in PrP-null and PrP-expressing neuronal cells |
Biochemical and biophysical research communications |
Medium |
15670743
|
| 2005 |
In yeast, mutations in Sti1 DP2 domain completely disrupt Sti1 function in vivo, while TPR1 and TPR2B have redundant roles in Hsp70 binding; a single amino acid alteration in TPR2A disrupts Hsp90 interaction but does not significantly affect function alone. |
Site-directed mutagenesis, genetic screen, co-immunoprecipitation in yeast |
Genetics |
Medium |
16219779
|
| 2006 |
Wild-type Hsp90 binds Sti1 in a nucleotide-independent manner in yeast cell extracts, while Sba1 and Cpr6 interact with Hsp90 specifically in the presence of the non-hydrolyzable ATP analog AMP-PNP; Hsp90 mutations altering ATP binding reduce Sti1 interaction in the presence of nucleotide. |
Co-immunoprecipitation from yeast extracts with wild-type and mutant Hsp90 forms, AMP-PNP competition |
Molecular and cellular biology |
Medium |
17101799
|
| 2007 |
Both TPR1 and TPR2B of Sti1 contribute redundantly to Hsp70 binding in vivo; TPR2A is required for Hsp90 interaction but requires TPR2B for full Hsp90 binding in isolation; TPR2A is sufficient for Sti1 dimerization; the DP2 domain is essential for in vivo function but dispensable for Hsp70/Hsp90 interaction or dimerization; Sti1 mutants with reduced Hsp70 interaction show reduced recovery of Hsp70 in Hsp90 complexes. |
Truncation mutagenesis, in vivo co-immunoprecipitation, in vitro binding assays with purified proteins |
The Biochemical journal |
High |
17300223
|
| 2007 |
Extracellular/secreted STI1 induces proliferation of human glioblastoma cells (A172) via MAPK (ERK) and PI3K signaling pathways, and this effect involves cellular prion protein (PrPC). |
Thymidine incorporation assay, pathway inhibitor experiments, extracellular STI1 application |
Glia |
Low |
17886292
|
| 2009 |
Interaction of PrPC with hop/STI1 induces loss of PrP helical structures (perturbation of PrP helix 143–153) and a C-terminal compaction of hop/STI1, as revealed by CD, fluorescence spectroscopy, and SAXS; free murine hop/STI1 is monomeric by both SAXS and size-exclusion chromatography. |
Circular dichroism (CD), fluorescence spectroscopy, small angle X-ray scattering (SAXS), size-exclusion chromatography |
FASEB journal |
Medium |
19703931
|
| 2010 |
Deletion of STI1 in yeast both suppresses Ssa1-21 (Hsp70 mutant)-mediated impairment of [PSI+] and blocks Hsp104-mediated curing of [PSI+] prions; Sti1 variants defective in Hsp70 or Hsp90 interaction cure less efficiently, and Hsp90 inhibitor abolishes curing, demonstrating Sti1 acts in prion curing through both Hsp70 and Hsp90 interactions. |
Genetic epistasis, STI1 deletion, domain-specific mutations, Hsp90 inhibitor treatment, prion-curing assays in yeast |
Molecular and cellular biology |
High |
20479121
|
| 2012 |
Sti1/Hop has a modular architecture: TPR2A is the high-affinity Hsp90-binding site; TPR1 and TPR2B bind Hsp70 with moderate affinity; DP1 and DP2 have homologous α-helical folds (determined by NMR); the TPR2A–TPR2B segment is the core Hsp90 inhibitory module; TPR2A and TPR2B are connected by a rigid linker orienting their binding sites in opposite directions, allowing simultaneous binding of TPR2A to Hsp90 C-terminal domain and TPR2B to Hsp70; DP2 is important for client activation in vivo. |
NMR structure determination of DP domains, crystal structure of TPR2A–TPR2B segment, in vitro binding assays, in vivo client activation assays |
The EMBO journal |
High |
22227520
|
| 2012 |
Sti1 stabilizes multiple regions in all three domains of Hsp90 and slows dimer dissociation; it inhibits Hsp90 ATPase by preventing N-terminal dimerization and docking of the N-terminal with the middle domain; crosslinking-MS identified Sti1 segments in close proximity to the Hsp90 N-terminal domain; the linker length between Hsp90 C-terminal dimerization domain and MEEVD motif is important for Sti1 association rates. |
Hydrogen exchange mass spectrometry (HX-MS), crosslinking mass spectrometry, mutant Hsp90 analysis |
The EMBO journal |
High |
22354036
|
| 2013 |
Sti1 modulates spatial quality control of amyloid-like proteins (Htt103Q, Rnq1) in yeast cytosol: loss of Sti1 exacerbates Htt toxicity and hinders foci formation; elevation of Sti1 suppresses toxicity and organizes small Htt103Q foci into larger perinuclear assemblies containing thioflavin-T-positive amyloid-like material. |
High-copy suppressor screen in yeast, fluorescence microscopy, thioflavin-T staining, toxicity assays |
Molecular biology of the cell |
Medium |
24109600
|
| 2014 |
Sti1/Hop is a dynamic elongated protein with a flexible N-terminal module and rigid C-terminal module; without Hsp90, Sti1 is more compact and TPR2B is the high-affinity Hsp70-binding site; in the presence of Hsp90, Hsp70 shifts its preference away from TPR2B; the linker connecting the two modules is crucial for Hsp70 interaction and client activation in vivo. |
Single-molecule fluorescence (FRET), NMR, truncation mutants, in vivo client activation assays, fluorescence cross-correlation spectroscopy |
Nature communications |
High |
25851214
|
| 2014 |
Cytoplasmic STI1 directly interacts with the small GTPase Rnd1; this interaction is specific for Rnd1 (not other Rnd family members); STI1 overexpression prevents Rnd1-plexin-A1-mediated cytoskeleton retraction in COS collapse assay and enhances neurite outgrowth in PC-12 cells. |
Co-immunoprecipitation, COS cell collapse assay, PC-12 neurite outgrowth assay, specificity tests with Rnd family members |
Experimental cell research |
Medium |
24690281
|
| 2014 |
Yeast Sti1 is phosphorylated at inhibitory sites; human Hop is also subject to inhibitory phosphorylation; phospho-mimetic variants of Hop have reduced ability to activate clients in vivo, reduced affinity for Hsp70, and reduced interaction with Hsp90 (for human Hop), inducing structural rearrangements in the protein core. |
Phospho-mimetic mutagenesis, in vivo client activation assays, affinity binding assays, structural analysis |
EMBO reports |
Medium |
25504578
|
| 2016 |
STIP1 co-immunoprecipitates with actin from HEK293T cells and directly interacts with actin in vitro via its C-terminal TPR2AB-DP2 domain; STIP1 can stimulate actin ATPase activity in vitro; STIP1 depletion leads to increased nuclear actin accumulation, F-actin disorganization, and altered cofilin/profilin levels. |
Co-immunoprecipitation from HEK293T cells, in vitro direct binding/ATPase assay, STIP1 knockdown with fluorescence imaging of actin structures, western blot for cofilin and profilin |
International journal of molecular sciences |
Medium |
32365744
|
| 2016 |
STIP1 interacts with the Axin scaffold protein, enhances the Axin–DVL2 interaction, and thereby activates β-catenin/TCF (Wnt) signaling in hepatocellular carcinoma cells. |
Co-immunoprecipitation, STIP1 knockdown/overexpression with downstream Wnt reporter |
Gene |
Low |
29596884
|
| 2016 |
STIP1 domains DP1, TPR1, and TPR2A all contribute to PrPC binding: DP1 binds the N-terminal region of PrP (residues 23–95), TPR1 and TPR2A bind the C-terminal region (residues 90–231); only TPR1 and TPR2A directly inhibit AβO binding to PrPC and AβO-induced neuronal cell death; the TPR2A–PrP interface is extensive and partially overlaps with the Hsp90-binding site, suggesting a PrP–STIP1–Hsp90 ternary complex. |
NMR chemical shift mapping, binding domain mapping with truncated STIP1 constructs, cell death assays, amyloid-beta oligomer competition binding assays |
The Biochemical journal |
Medium |
27208175
|
| 2016 |
Deletion of STI1 in yeast causes alterations in mitochondrial morphology and lower steady-state levels of a subset of mitochondrial proteins; double deletion of STI1 with mitochondrial import factors MIM1 or TOM20 shows synthetic growth phenotype; recombinant cytosolic domains of Tom20 and Tom70 bind Sti1 in vitro, suggesting Sti1 plays a direct or indirect role in mitochondrial protein import. |
Site-directed photo-crosslinking in yeast, genetic epistasis (double deletion growth assays), in vitro binding assay with Tom receptor domains, mitochondrial morphology imaging |
The FEBS journal |
Medium |
27412066
|
| 2017 |
Three S100A1 dimers associate with one STIP1 molecule in a calcium-dependent manner; each STIP1 TPR domain (TPR1, TPR2A, TPR2B) binds one S100A1 dimer with different affinities (TPR2B highest); S100A1 binds each TPR domain through a common interface (α-helices III and IV) accessible only after calcium-induced conformational change; TPR2B binding involves insertion of S100A1 into its hydrophobic cleft. |
Isothermal titration calorimetry (ITC), domain-specific binding assays with isolated TPR domains, calcium-dependence studies |
The Biochemical journal |
High |
28408431
|
| 2018 |
Hop/STIP1 depletion or overexpression reduces emerin protein levels via proteasomal and lysosomal pathways; Hop and emerin co-immunoprecipitate in a complex that also contains Hsp70 but not Hsp90; TPR2AB domain of Hop is required for the Hop-emerin association; loss of Hop or emerin causes nuclear deformation and decreased nuclear size; nuclear defects from Hop loss are rescued by emerin overexpression. |
Co-immunoprecipitation, STIP1 depletion/overexpression, proteasome/lysosome inhibitor experiments, nuclear morphology imaging, rescue experiment |
Biochemical and biophysical research communications |
Medium |
30449594
|
| 2020 |
Human cell lines and budding yeast with deletion of STIP1/STI1 display reduced proteasome activity due to inefficient capping of the 20S core particle with regulatory particles; unexpectedly, knockout cells are more proficient at preventing protein aggregation and promoting protein refolding, because a more efficient prokaryote-like Hsp70–Hsp90 binary complex (without Hop restraint) compensates; this was also demonstrated in vitro. |
Gene knockout in human cells and yeast, in vitro reconstitution of Hsp70–Hsp90 chaperone activity, proteasome activity assays, protein aggregation/refolding assays |
Nature communications |
High |
33239621
|
| 2021 |
STI1 co-immunoprecipitates α-synuclein; NMR analyses show direct interaction of α-synuclein with the TPR2A domain (but not TPR1 or TPR2B) of STI1, involving the C-terminal domain of α-synuclein; the STI1 TPR2A domain facilitates S129 phosphorylation of α-synuclein by Polo-like kinase 3 in vitro; mice over-expressing STI1 and Hsp90β show elevated S129 α-synuclein phosphorylation and inclusion formation; reduced STI1 function decreases inclusion formation and phosphorylation while mitigating motor and cognitive deficits. |
Co-immunoprecipitation, NMR interaction mapping, in vitro phosphorylation assay with PLK3, mouse model with altered STI1 expression |
Acta neuropathologica |
High |
36121476
|
| 2021 |
Hsp90 and its co-chaperone Sti1 modulate TDP-43 misfolding, inclusion formation, aggregation, and cellular toxicity; Sti1 specifically interacts with TDP-43 and strongly modulates TDP-43 toxicity in a dose-dependent manner in yeast and mammalian neuronal cells. |
Co-immunoprecipitation, TDP-43 aggregation assay, toxicity assays in yeast and mammalian neuronal cells, genetic manipulations of STI1/Hsp90 |
FASEB journal |
Medium |
33908654
|
| 2021 |
STIP1 can be isolated in a complex with actin and Hsp90 from HEK293T cells; STIP1 directly interacts with actin via the C-terminal TPR2AB-DP2 domain in vitro; STIP1 can stimulate the in vitro ATPase activity of actin. |
Co-immunoprecipitation, in vitro direct binding assay, in vitro ATPase stimulation assay |
International journal of molecular sciences |
Medium |
32365744
|
| 2022 |
JAK2 phosphorylates STIP1 at tyrosine residues Y134 and Y152, promoting STIP1 protein stability, inducing nuclear-cytoplasmic shuttling, and promoting STIP1 secretion into the extracellular space; JAK2-mediated STIP1 phosphorylation enhances cell viability and increases resistance to cisplatin-induced cell death; disrupting STIP1–JAK2 interaction decreases JAK2 protein levels. |
Site-directed mutagenesis of phosphorylation sites, cell-penetrating inhibitory peptides, immunoblotting for stability, nuclear-cytoplasmic fractionation, ELISA for secretion, cell viability assays |
International journal of molecular sciences |
Medium |
35269562
|
| 2023 |
STIP1 binds to HSP40, HSP70, and HSP90 in rat H9c2 cardiomyocytes; overexpression of STIP1 promotes the transition of Cx43 from Cx43-HSP70 to Cx43-HSP90 complexes and inhibits Cx43 ubiquitination; knockdown of STIP1 has the opposite effect; HSP90 inhibition counteracts the inhibitory effect of STIP1 overexpression on Cx43 ubiquitination. |
Co-immunoprecipitation, STIP1 overexpression/knockdown, HSP90 inhibitor treatment, ubiquitination assays in H9c2 cardiomyocytes |
Cytotechnology |
Medium |
37187948
|
| 2023 |
The lncRNA LINC01226 binds STIP1 protein, leads to disassembly of the STIP1–HSP90 complex, elevates HSP90–β-catenin interactions, stabilizes β-catenin protein, and activates Wnt/β-catenin signaling to promote gastric cancer progression. |
RNA-protein pulldown, co-immunoprecipitation, LINC01226 overexpression/knockdown with downstream β-catenin/TCF assays |
Cancer letters |
Low |
37806517
|
| 2024 |
During proteostatic stress, Sti1 forms cytoplasmic inclusions in yeast and mammalian cells that overlap with misfolded proteins; deletion of STI1 causes accumulation of soluble misfolded ubiquitinated proteins and activates the heat shock response; Sti1 sequesters misfolded proteins during stress independently of its Hsp90 ATPase regulatory function. |
Fluorescence imaging of inclusions in yeast and mammalian cells, soluble/insoluble protein fractionation, ubiquitin accumulation assay, heat shock reporter assay, STI1 deletion |
The FEBS journal |
Medium |
39739753
|
| 2025 |
The mitochondrial targeting signal (MTS) directly engages the co-chaperones of Hsc70 including Stip1/HOP via site-specific photo-crosslinking; STIP1/Hop and St13 facilitate chaperone retention on the mature domain of mitochondrial precursor proteins; during acute import stress, this Hsp90 co-chaperone interaction (requiring the MTS) buffers precursor degradation and maintains import competence. |
Site-specific photo-crosslinking in cells, biochemical reconstitution, import stress experiments |
bioRxiv (preprint)preprint |
Medium |
bio_10.1101_2025.01.18.633710
|
| 2025 |
STIP1/HOP directly interacts with α-synuclein via two binding motifs in the C-terminus of α-synuclein that dynamically compete for the TPR2A domain of STIP1; STIP1 binding attenuates α-synuclein fibril formation while promoting accumulation of high-molecular-weight amorphous and A11-positive oligomeric species that are more cytotoxic to neuronal cells. |
NMR interaction mapping, in vitro aggregation assays, A11 oligomer dot-blot, neuronal cell viability assays |
bioRxiv (preprint)preprint |
Medium |
bio_10.1101_2025.03.26.645247
|
| 2025 |
STIP1 interacts with adenosylhomocysteinase (AHCY/SAHH) and changes AHCY conformation; STIP1 facilitates AHCY binding to lactate dehydrogenase A (LDHA), stimulating glycolysis; AHCY then recruits PRMT3 to methylate LDHA at R106, inhibiting ubiquitination-mediated AHCY degradation; STIP1 knockout in mice inhibits 4NQO-induced esophageal tumorigenesis. |
Co-immunoprecipitation, conformational assay, in vivo mouse knockout, glycolysis assays, methylation assays |
Exploration (Beijing, China) |
Low |
41163796
|